Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704814 | SCV000730374 | likely benign | not provided | 2020-02-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001478501 | SCV001682772 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002413766 | SCV002721128 | likely benign | Cardiovascular phenotype | 2020-02-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001704814 | SCV005074547 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
Clinical Genetics, |
RCV000603159 | SCV001920118 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000603159 | SCV001974325 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001704814 | SCV002035683 | likely benign | not provided | no assertion criteria provided | clinical testing |